Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients.
Episode Resources
- Connect with Arundhati Parmar
- aparmar@medcitynews.com
- https://twitter.com/aparmarbb?lang=en
- https://medcitynews.com/
- Connect with Sarah Boyce
- https://www.linkedin.com/in/sarah-boyce-7775808/
- http://www.aviditybiosciences.com/about-us/
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
